rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CLPT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ClearPoint Neuro: Momentum Building Across The Business (NASDAQ:CLPT)

      ClearPoint Neuro posted strong Q3 results as CAL revenue and equipment sales grow.

      Nov 9Seeking AlphaCLPT
      ClearPoint Neuro, Inc. Q3 2026 Earnings Call Summary
      Oct 29Yahoo FinanceCLPT
      ClearPoint Neuro Inc (CLPT) (Q3 2026) Earnings Call Highlights: Record Revenue Growth and ...
      Oct 29Yahoo FinanceCLPT
      Clearpoint Neuro stock price target lowered to $18 by Stifel
      Oct 29Investing.comCLPTSF
      What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call
      Oct 29Yahoo FinanceCLPT
      Clearpoint Neuro earnings beat by $0.08, revenue fell short of estimates
      Oct 29Investing.comCLPT
      ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates
      Oct 28Yahoo FinanceCLPT
      Earnings call transcript: ClearPoint Neuro tops growth expectations in Q3 2026
      Oct 28Investing.comCLPT
      ClearPoint Neuro Q3 2026 Earnings Call Transcript
      Oct 28BenzingaCLPT
      ClearPoint Neuro Reports Third Quarter 2026 Results
      Oct 28Yahoo FinanceCLPT
      ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
      Oct 14Yahoo FinanceCLPT
      ClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To Hold (NASDAQ:CLPT)
      Oct 1Seeking AlphaCLPTQURE
      Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)

      Detailed price information for Axsome Thera (AXSM-Q) from The Globe and Mail including charting and trades.

      Sep 30The Globe and MailAXSMCLPT
      ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
      Sep 29Yahoo FinanceCLPTQURE
      ClearPoint Neuro stock tumbles on uniQure trial setback
      Sep 29Investing.comCLPTQURE
      Stifel reiterates Clearpoint Neuro stock rating citing CGT focus
      Sep 15Investing.comCLPT
      ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
      Sep 4Yahoo FinanceCLPT

      This is the newest page. Registered accounts read further back.